Zyprexa has been linked to the early onset of diabetes, hyperglycemia, or other diabetes-related complications that can result in coma or death. Researchers identified 289 cases of diabetes in patients who had been given Zyprexa. Of these 289 cases:
225 were newly diagnosed diabetic patients
100 developed ketosis, a serious diabetes-related complication
22 developed pancreatitis, a life-threatening inflammation of the pancreas
23 died
71% occurred within six months of starting treatment with Zyprexa.